TARO News and Press, Taro Pharmaceutical Industries Ltd. From 07/23/20

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that its wholly-owned subsidiary, Taro Pharmaceuticals U.S.A., Inc. (“Taro” or the “Company”), has resolved all cases involving the Company in connection with the multi-year investigations by the Depa...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2020, after the close of market on Wednesday, July 29, 2020. The release will be accessible on Taro’s website at www.taro.com . About...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company") announced that its Annual Report on Form 20-F for the fiscal year ended March 31, 2020, filed with the Securities and Exchange Commission (the “SEC”), is available within the Investor...

A coalition of 51 attorneys general in the U.S. has filed an antitrust complaint  in federal court against 26 companies making generic dermatology drugs and 10 executives at these firms claiming wide-spread price-fixing, marketing allocating and bid-rigging related to over 80 different...

It is no secret that prescription drug prices in America are the highest among all developed nations. A variety of factors have contributed to the issue, such as a lack of universal healthcare coverage, the staggering cost of conducting clinical trials to get drugs to approval, and price gougin...

Taro Pharmaceutical Industries Ltd. (TARO) Q4 2020 Results Earnings Conference Call May 20, 2020, 08:00 AM ET Company Participants William Coote - Assistant Vice President of Business Finance & Investor relations & Treasurer Dilip Shanghvi - Chairman of the Board of Directo...

Taro Pharmaceutical (NYSE: TARO ): Q4 GAAP EPS of $1.42 misses by $0.11 . More news on: Taro Pharmaceutical Industries Ltd., Earnings news and commentary, Healthcare stocks news, Read more ...

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2020. Quarter ended March 31, 2020 Highlights ─ compared to March 31, 2019 Net sales of ...

Earnings Call to be Conducted Wednesday, May 20 at 8:00 am ET Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for year ended March 31, 2020, on Tuesday, May 19, 2020. The Company will conduct an earnings call at 8:00 am...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today announced the appointment of Daphne Huang as Vice President, CFO and Chief Accounting Officer, effective today. Ms. Huang has over 20 years of senior executive experience in financ...